Who owns KAIROS PHARMA LTD?
- Ticker: KAPA
- CUSIP Number: 48301n104
Tip: Access positions for across all investors
Analyze quarterly positions in Kairos Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kairos Pharma stock
Who bought or sold KAIROS PHARMA LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 310k | $119k | 100% | Jun 2026 |
|
| Vanguard Capital Management | 232k | $89k | 0% | Jun 2026 |
|
| Virtu Financial | 82k | $31k | 100% | Jun 2026 |
|
| Geode Capital Management | 79k | $30k | -29% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 64k | $25k | 0% | Jun 2026 |
|
| Aptus Capital Advisors | 44k | $17k | 0% | Jun 2026 |
|
| SevenBridge Financial | 44k | $17k | 0% | Jun 2026 |
|
| Jane Street | 34k | $13k | 100% | Jun 2026 |
|
| Susquehanna International | 29k | $11k | 100% | Jun 2026 |
|
| State Street Corporation | 24k | $14k | 0% | Mar 2026 |
|
| XTX Topco | 15k | $5.7k | 100% | Jun 2026 |
|
| UBS Group | 6.3k | $2.4k | 100% | Jun 2026 |
|
| Tower Research Capital | 3.7k | $1.4k | -6% | Jun 2026 |
|
| Barclays | 723.00 | $276.981300 | 100% | Jun 2026 |
|
| Citigroup | 10.00 | $6.000000 | 100% | Mar 2026 |
|
Who sold out of Kairos Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Investments | Mar 2026 | 40k | $22k |
| Hrt Financial | Mar 2026 | 22k | $12k |
| Two Sigma Securities | Mar 2026 | 16k | $9.1k |